Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Permits And Licenses topic
No spam. Unsubscribe anytime.
Committee adopts amendment and advances bill to prohibit conditioning permits on unrelated approvals
Summary
Senate Bill 12 would prohibit a licensing or permitting authority from conditioning issuance of a permit on issuance of another agency’s permit unless state or federal law requires it. The committee adopted an amendment to preserve federal and other legal exceptions, heard multiple public comments, and forwarded the bill with a favorable report.
Senate Bill 12, aimed at preventing permitting entities from "stacking" approvals so that obtaining one permit is conditioned on unrelated clearances from other agencies, advanced from committee after members adopted an amendment to preserve exceptions required by federal or other state law.
The sponsor framed the bill as a response to lengthy permit timelines that sometimes result when different agencies require sequential approvals, saying the result can be to "kill the business before it ever started" by turning a multi‑week process into months. The committee adopted an amendment adding language—"unless otherwise specified by state or federal law or regulation"—to preserve any federal or state legal requirements that already mandate sequencing.
The committee held an extended public hearing with several stakeholders. Baker Allen, director of governmental affairs for the Alabama League of Municipalities, said the League opposed SB 12, arguing it could undermine municipalities’ ability to ensure state requirements are met and could produce unintended consequences such as businesses acting without required environmental or health approvals. Trey Czar with the Alabama Associated General Contractors supported the bill, saying it would end cycles where projects are delayed because multiple entities each withhold a permit while awaiting another agency’s permit. Dean Argo of the Alabama ABC voiced concerns about expedited liquor licensing and the need for thorough vetting, citing fingerprint and background checks outside local control. Susan Alverson of the Alabama Board of Pharmacy said federal reviews by DEA and FDA can delay licensing beyond 45 days and noted the amendment preserves federal requirements.
Committee members discussed the need to protect federal funding and public‑safety processes while reducing unnecessary administrative delays. After debate the committee adopted the amendment and approved a favorable report; a subsequent long roll recorded both 'No' and 'Aye' votes by named senators in committee minutes.
